Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
Condition: Triple Negative Breast Cancer Intervention: Drug: oral etoposide + anlotinib Sponsor: Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials